Malignant Tumor

• CLINICAL_TRIALS trial_result · 2025-06-23
  Clinical Trial Update: A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors [Phase 1]

  This Phase 1 trial evaluating ES102, an OX40 agonist, in combination with JS001 in patients with advanced solid tumors has completed.

• CLINICAL_TRIALS trial_result · 2023-07-20
  Clinical Trial Update: A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]

  Clinical trial update for IAP0971 in patients with advanced malignant tumors spanning Phase 1 and Phase 2.

• CLINICAL_TRIALS trial_result · 2022-12-07
  Clinical Trial Update: QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors [Phase 2]

  Phase 2 trial update for QL1604 monotherapy in dMMR or MSI-H advanced solid tumors (advanced malignant tumor).

• CLINICAL_TRIALS trial_result · 2022-04-29
  Clinical Trial Update: Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo [Phase 2]

  Phase 2 clinical trial evaluating correlation between immunoglobulin and liposomal doxorubicin in vivo for advanced malignant tumors.

• CLINICAL_TRIALS trial_result · 2020-12-17
  Clinical Trial Update: Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine [Phase 1, Phase 2]

  Phase 1/2 trial evaluating antigen peptide-specific DC-CTL cells with decitabine for malignant tumors is in early testing with unknown curre…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-11-03
  Clinical Trial Update: Additive Homeopathy in Cancer Patients [Phase 3]

  Phase 3 clinical trial evaluating additive homeopathy in cancer patients has completed; results posted in 2020.

• CLINICAL_TRIALS trial_result · 2020-08-18
  Clinical Trial Update: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor [Phase 2]

  Phase 2 clinical trial update for TQ-B3101 capsules in subjects with advanced malignant tumor.

• CLINICAL_TRIALS trial_result · 2019-04-30
  Clinical Trial Update: Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor [Phase 1, Phase 2]

  A clinical trial update for ROBO1-specific BiCAR-NK/T cells evaluating safety and preliminary efficacy in malignant tumors (Phase 1/2).

• CLINICAL_TRIALS trial_result · 2018-01-02
  Clinical Trial Update: Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury [Phase 4]

  Phase 4 trial update evaluating whether intraoperative dexmedetomidine affects the development of acute kidney injury.